Hyperlipidemia
Episodes 1-16 of 27
John Kastelein, MD, PhD
Stephen Nicholls, FRACP, FACC, FESC, FAHA
John Kastelein, MD, PhD
Stephen Nicholls, FRACP, FACC, FESC, FAHA
Erin D. Michos, MD, MHS, FACC, FAHA, FASE
Erin D. Michos, MD, MHS, FACC, FAHA, FASE
Christie M. Ballantyne, MD, FACP, FACC
Daniel Gaudet, MD, PhD
P. Gabriel Steg, MD
Pam R. Taub, MD, FACC, FASPC
Erik Stroes, MD, PhD
P. Gabriel Steg, MD
Pam R. Taub, MD, FACC, FASPC
Erik Stroes, MD, PhD
- MinuteCE®
The evolving need and challenges to reach LDL-c targets in high-risk patients
1.00 program creditProf. Kausik Ray, MBChB, MD, MPhil
Lale Tokgözoğlu, MD
Fabrice Martens, MD, PhD, FESC
- MinuteCE®
Novel oral pathways in LDL-C lowering therapy: The new promise of CETPi
1.00 program creditErin D. Michos, MD, MHS, FACC, FAHA, FASE
Prof. Kausik Ray, MBChB, MD, MPhil
Lale Tokgözoğlu, MD
Fabrice Martens, MD, PhD, FESC
Erin D. Michos, MD, MHS, FACC, FAHA, FASE
Stephen Nicholls, FRACP, FACC, FESC, FAHA
John Kastelein, MD, PhD
Roxana Mehran, MD
- Prev
- Next